Explore

Trendline Trendline
Covera Health and Medmo Merge to Enhance AI Diagnostic Imaging and Care Coordination

Covera Health and Medmo Merge to Enhance AI Diagnostic Imaging and Care Coordination

Covera Health and Medmo Merge to Enhance AI Diagnostic Imaging and Care Coordination
Rapid Read Rapid Read
AI Chatbot Developed to Enhance Patient Self-Triage with Medical Protocols

AI Chatbot Developed to Enhance Patient Self-Triage with Medical Protocols

A new artificial intelligence-powered chatbot has been developed to assist individuals in making informed decisions about their health symptoms. This tool, created by a team at the University of California San Diego, aims to improve the self-triage process by using symptom-based flowcharts to guide users on whether to self-care, schedule a medical visit, or seek emergency care. The chatbot is designed to provide reliable medical guidance, reducing unnecessary hospital visits and ensuring timely care for those in need. It operates by engaging in conversational exchanges with users, interpreting their symptoms, and following established medical protocols to offer recommendations. The system is trained on medical flowcharts from the American Medical Association and has been tested in over 30,000 simulated conversations, achieving high accuracy in selecting appropriate medical guidance.
Trendline Trendline
SquareMind Secures $18M to Launch Robotic Dermatology Platform in U.S. and Europe

SquareMind Secures $18M to Launch Robotic Dermatology Platform in U.S. and Europe

SquareMind Secures $18M to Launch Robotic Dermatology Platform in U.S. and Europe
Rapid Read Rapid Read
U.S. Hospitals Implement AI Chatbots Amidst Doctor Concerns Over Patient Safety

U.S. Hospitals Implement AI Chatbots Amidst Doctor Concerns Over Patient Safety

Healthcare systems in the U.S. are increasingly deploying AI chatbots to assist patients with medical inquiries and appointment scheduling. Hartford HealthCare in Connecticut has introduced Patient GPT, while Sutter Health and Reid Health have launched Emmie, a chatbot integrated with Epic's MyChart. These tools aim to provide quick health guidance, especially in underserved rural areas where healthcare messages are frequent. Despite their potential to reduce waiting times and improve accessibility, there is a division among doctors regarding their safety and effectiveness. Some experts, like Nigam Shah from Stanford University, view these tools as beneficial for bridging care gaps outside clinic hours. However, concerns remain about the accuracy and monitoring of these AI systems, as highlighted by Suchi Saria from Johns Hopkins University.
Rapid Read Rapid Read
Solace Health Expands Care Navigation Services to Commercially Insured Patients

Solace Health Expands Care Navigation Services to Commercially Insured Patients

Solace Health, a patient advocacy platform, has announced the expansion of its care navigation services to include most major health plans, such as UnitedHealthcare and Anthem Blue Cross Blue Shield. Previously, Solace's services were primarily available to Medicare and Medicare Advantage patients. This expansion allows many commercially insured patients to access Solace's services, although specific commercial plans were not detailed in the announcement. Solace pairs each patient with a dedicated healthcare advocate to assist with navigating the complex healthcare system, which includes coordinating care, managing records, and resolving billing issues. The company was founded in 2022 by CEO Jeremy Gurewitz and Chief Product Officer Sara Sargent, inspired by Gurewitz's personal experience with his mother's cancer diagnosis. Solace claims that 98% of patients feel more in control and 92% experience better health outcomes after working with their advocates, based on a 2023 report by the Coalition of Healthca...
Rapid Read Rapid Read
Utah Medical Licensing Board Calls for Suspension of AI Prescription Pilot

Utah Medical Licensing Board Calls for Suspension of AI Prescription Pilot

The Utah Medical Licensing Board has urged the state to suspend a pilot program involving an AI-powered prescription medication refill system developed by Doctronic. The system, which automates routine prescription renewals, has raised concerns about patient safety. The board was not consulted before the program's implementation and argues that prescription refills require clinical oversight to adjust doses and monitor for side effects. The pilot, currently in its first phase, involves physician review of AI-generated renewals. State officials have defended the program, citing rigorous safety evaluations and ongoing physician involvement.
Trendline Trendline
SquareMind Secures $18 Million to Revolutionize Dermatology with AI and Robotics

SquareMind Secures $18 Million to Revolutionize Dermatology with AI and Robotics

SquareMind Secures $18 Million to Revolutionize Dermatology with AI and Robotics
Rapid Read Rapid Read
Stanford Study Finds AI Enhances Physician Decision-Making in Clinical Management

Stanford Study Finds AI Enhances Physician Decision-Making in Clinical Management

A study led by Stanford Medicine has found that artificial intelligence (AI) can significantly enhance physician decision-making in clinical management. The research, led by Dr. Jonathan H. Chen, explored the use of AI-powered chatbots in assisting with complex medical decisions beyond diagnosis, such as treatment planning and care management. The study revealed that when physicians used AI as a decision support tool, their performance matched that of the AI alone, highlighting a synergistic relationship. This suggests that AI can complement human clinical judgment, leading to improved healthcare outcomes.
Rapid Read Rapid Read
Stanford Medicine Study Finds AI Enhances Physician Decision-Making in Clinical Management

Stanford Medicine Study Finds AI Enhances Physician Decision-Making in Clinical Management

A study led by Dr. Jonathan H. Chen at Stanford University has explored the role of artificial intelligence (AI) in enhancing clinical management decision-making. The research focused on AI-powered chatbots, which have already shown proficiency in diagnosing complex medical conditions. The study aimed to determine if these AI systems could also assist in the nuanced decision-making required for post-diagnosis patient care. The findings revealed that chatbots, when used independently, outperformed physicians who relied solely on traditional internet searches and medical references. However, when physicians incorporated AI into their workflow, their performance matched that of the AI alone, indicating a synergistic effect. This suggests that human clinical judgment, when enhanced by AI, can achieve superior outcomes compared to either working in isolation.
Rapid Read Rapid Read
AI's Potential to Transform Medicine Hinges on Regulatory Frameworks

AI's Potential to Transform Medicine Hinges on Regulatory Frameworks

Artificial intelligence (AI) is increasingly being used in medicine, with one in three Americans turning to AI chatbots for medical advice. However, the lack of consistent regulation poses challenges. Some states, like New York, are considering strict regulations, while others, like California, are taking a more balanced approach. The federal government is also involved, with the FDA updating guidelines to allow AI tools to assist doctors with less oversight. The potential of AI to democratize access to healthcare is significant, but it requires robust regulatory frameworks to ensure safety and effectiveness.
Rapid Read Rapid Read
GE HealthCare Initiates Phase 2/3 Trial for Manganese-Based MRI Contrast Agent with FDA Fast Track Designation

GE HealthCare Initiates Phase 2/3 Trial for Manganese-Based MRI Contrast Agent with FDA Fast Track Designation

GE HealthCare has announced the dosing of the first patient in the Phase 2/3 LUMINA clinical trial for its manganese-based MRI contrast agent, mangaciclanol, at the Mayo Clinic in Rochester, Minnesota. This investigational agent, which has received Fast Track designation from the U.S. Food and Drug Administration (FDA), is being developed as a potential alternative to gadolinium-based MRI contrast agents. Mangaciclanol aims to enhance the visualization of abnormal structures during MRI procedures, offering comparable diagnostic capabilities to existing gadolinium-based agents. Unlike gadolinium, manganese is a naturally occurring element in the body, which may reduce concerns about retention and environmental impact.
Rapid Read Rapid Read
AI and Age Tech Spark Debate at Major Aging Conference

AI and Age Tech Spark Debate at Major Aging Conference

At the On Aging 2026 conference in Atlanta, AI and age tech were central topics of discussion, sparking debate among attendees. The conference highlighted the use of AI in predictive analytics for elder care, such as early detection of Alzheimer's and assistive technologies like wearables. While some participants were optimistic about the potential of AI to improve care for older adults, others expressed concerns about the social implications, such as isolation from family and community. The event also addressed broader themes of social connection, equity, and justice in aging, emphasizing the need for inclusive and equitable tech solutions.